Cyclacel Pharmaceuticals Inc. buy Roth Mkm
Start price
03.05.24
/
50%
€0.22
Target price
03.05.25
€10.21
Performance (%)
-
End price
04.05.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cyclacel Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by Roth_Mkm for this prediction
In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target lowered by analysts at Roth Mkm from $21.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat
In the thread Trading Cyclacel Pharmaceuticals Inc.
Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.22
19.12.23
19.12.23
€19.12
19.12.24
19.12.24
-
20.12.24
20.12.24
